✦ LIBER ✦

Optimal dosage and differences in therapeutic efficacy of IGIV in Kawasaki disease

✍ Scribed by ZENSHIRO ONOUCHI; MASAYOSHI YANAGISAWA; TSUNEO HIRAYAMA; NOBUYUKI KIYOSAWA; HIROSHI MATSUDA; MITSUYOSHI NAKASHIMA

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of immunoglobulin re

✍ Fernanda Falcini; Marialuisa Ermini; Sandra Trapani; Giovanni Taccetti; MD 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 187 KB

Differences in immunoglobulin preparatio

✍ Halûk Yavuz; Ahmet Özel 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 190 KB

Comparative safety and efficacy of two i

✍ Elaine A. Rosenfeld; Stanford T. Shulman; Kathleen E. Corydon; William Mason; Ma 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 392 KB

Efficacy of Different Therapeutic Option

✍ Bermejo, Fernando ;Garrido, Elena ;Chaparro, Maria ;Gordillo, Jordi ;Mañosa, Mír 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 38 KB

In Vivo Liver Electroporation: Optimizat

✍ Jaichandran, S.; Yap, Steven T.B.; Khoo, Adrian B.M.; Ho, Liam Pock; Tien, Sim L 📂 Article 📅 2006 🏛 Mary Ann Liebert 🌐 English ⚖ 390 KB

Therapeutic efficacy and adverse effects

✍ Shin-ichiro Hamano; Shintaro Yamashita; Manabu Tanaka; Satoshi Yoshinari; Motoyu 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 94 KB